Peter Soparkar, Chief Legal Officer at Adverum Biotechnologies, Inc. (ADVM), bought 7,692 shares at $13.00 ($100K) on 2020-08-17, disclosed to the SEC on 2020-08-19.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| ADVM | SELL | 2023-03-17 | $10K | — | Filing → |
| ADVM | SELL | 2022-09-21 | $14K | — | Filing → |
| ADVM | BUY | 2022-04-20 | $25K | — | Filing → |